print this page | email this page
December, 2004 - Catalyst For a Cure investigators report on progress
The four principal investigators in the Catalyst For a Cure (CFC) team reported third year results from their collaborative research at the 2004 CFC Dinner and Report to Donors in San Francisco. The event marked the completion of the first 3-year phase of the CFC research consortium. The scientists reported their findings and talked about the direction their research would take in the next 3-year phase, 2005 to 2007.
David Calkins, PhD, principal investigator from Vanderbilt University, emphasized that their research results indicated glaucoma is not a disease of the eye, but a disease of the central nervous system. “Glaucoma bears striking similarities to diseases such as Alzheimer’s, Parkinson’s, Lou Gehrig’s disease, and Huntington’s disease,” Dr. Calkins said. “We think it is those similarities that are going to lead us through the next three years in our search for therapeutic targets for glaucoma.”